2013 Activities Schedule

Date	Workshop/Forum/Discussion Meeting
23 January	4^th Annual Regulators Forum, Beijing, China
24-25 January	Workshop: Quality decision making, Beijing, China
12 March	HTA Industry Discussion Meeting, UK
13-14 March	Workshop: The patient voice in clinical development: Can patients contribute to the benefit-risk assessment of medicines? UK
20-21 June	Workshop: Implementing an internationally acceptable framework for the benefit-risk assessment of mediciens: How close are we to this objective, Washington, DC, USA
TBD September	HTA Agency Discussion Meeting, TBD
2-3 October	Workshop: Utilisation of an agreed overarching benefit-risk decision framework by both HTA and regulatory agencies: Would this facilitate understanding of the different outcomes, UK
11-12 November	Emerging Markets Industry Discussion Meeting, Heathrow, UK
13 November	HTA Industry Discussion Meeting, Heathrow, UK
14 November	HTA Agency Discussion Meeting, Heathrow, UK
2-3 December TBC	Workshop: Good practice in health technology assesment Building quality into HTA/coverage decision making: What are the features of good practice in HTA, UK
W/O 9 December	Technical Forum: Exploring ways to maximise the value of PBRERs: Addressing agency needs and company approaches to post-approval benefit-risk assessment